{"id":152,"date":"2019-05-08T00:00:00","date_gmt":"2019-05-08T00:00:00","guid":{"rendered":"http:\/\/test.semmelweis.hu\/kerpel\/150-45349\/"},"modified":"2019-05-08T00:00:00","modified_gmt":"2019-05-08T00:00:00","slug":"150-45349","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/kerpel\/2019\/05\/08\/150-45349\/","title":{"rendered":"Semmelweis Symposium id\u00e9n is!"},"content":{"rendered":"<p><strong>Szeretettel h\u00edvjuk az \u00e9rdekl\u0151d\u0151ket az idei Semmelweis Symposiumra is, r\u00e9szletek az al\u00e1bbiakban olvashat\u00f3k.<\/strong><\/p>\n<p>Szeretettel h\u00edvjuk az \u00e9rdekl\u0151d\u0151ket a 2013. nov. 7-9. k\u00f6z\u00f6tt az SE EOK \u00e9p\u00fclet\u00e9ben megrendez\u00e9sre ker\u00fcl\u0151 Semmelweis Symposium-ra, melynek t\u00e9m\u00e1ja <strong>&#8222;Molecular Mechanisms and Therapeutic Targets in Inflammatory Diseases&#8221; <\/strong> lesz.<\/p>\n<p>A f\u0151 el\u0151ad\u00e1st <strong>Ravinder Maini<\/strong>, a Lasker Award d\u00edjazottja, a TNF-antagonista ter\u00e1pia megalapoz\u00f3ja tartja. A tov\u00e1bbi el\u0151ad\u00e1sokat szint\u00e9n a t\u00e9ma legelismertebb nemzetk\u00f6zi kutat\u00f3i tartj\u00e1k.<\/p>\n<p>A konferencia kiv\u00e1l\u00f3 lehet\u0151s\u00e9get teremt az alapkutat\u00f3k, a klinikusok \u00e9s a gy\u00f3gyszeripar k\u00e9pvisel\u0151i k\u00f6zti interakci\u00f3kra. A konferencia sor\u00e1n sz\u00e1mos lehet\u0151s\u00e9g lesz fiatal kutat\u00f3k bemutatkoz\u00e1s\u00e1ra is kiv\u00e1lasztott el\u0151ad\u00e1s, illetve poszter-bemutat\u00e1s form\u00e1j\u00e1ban.<\/p>\n<p>Minden \u00e9rdekl\u0151d\u0151t b\u00e1tor\u00edtunk \u00e9s v\u00e1runk a konferenci\u00e1ra val\u00f3 jelentkez\u00e9sre \u00e9s r\u00e9szv\u00e9telre. A Semmelweis Egyetem kutat\u00f3i r\u00e9sz\u00e9re az \u00e9tkez\u00e9sek n\u00e9lk\u00fcli r\u00e9szv\u00e9tel szept. 30-ig val\u00f3 jelentkez\u00e9s eset\u00e9n ingyenes, \u00e9s a teljes csomag is jelent\u0151s kedvezm\u00e9nnyel vehet\u0151 ig\u00e9nybe.<\/p>\n<p>Az absztraktok bead\u00e1s\u00e1nak hat\u00e1rideje: <strong>2013. szept. 30.<\/p>\n<p>A konferenci\u00e1val kapcsolatos tov\u00e1bbi inform\u00e1ci\u00f3kat a <u><a href=\"http:\/\/www.semmelweis-symp2013.hu\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-size: medium\">www.semmelweis-symp2013.hu<\/a><\/u> honlapon tal\u00e1lnak.<\/p>\n<p>MEGH\u00cdVOTT EL\u0150AD\u00d3K<\/p>\n<p>Ravinder Maini <em>(London, UK)<\/em> &#8211; Keynote speaker<\/p>\n<p>Edit Buz\u00e1s <em>(Budapest, Hungary)<\/em><\/p>\n<p>Oliver Distler <em>(Z\u00fcrich, Switzerland)<\/em><\/p>\n<p>Andr\u00e1s Falus <em>(Budapest, Hungary)<\/em><\/p>\n<p>Steffen Gay <em>(Z\u00fcrich, Switzerland)<\/em><\/p>\n<p>Lionel Ivashkiv <em>(New York, USA)<\/em><\/p>\n<p>Lars Klareskog <em>(Stockholm, Sweden)<\/em><\/p>\n<p>P\u00e9ter Lakatos <em>(Budapest, Hungary)<\/em><\/p>\n<p>Erzs\u00e9bet Ligeti <em>(Budapest, Hungary)<\/em><\/p>\n<p>Clifford Lowell <em>(San Francisco, USA)<\/em><\/p>\n<p>Andrew Luster <em>(Boston, USA)<\/em><\/p>\n<p>Attila M\u00f3csai <em>(Budapest, Hungary)<\/em><\/p>\n<p>Gy\u00f6rgy Nagy <em>(Budapest, Hungary)<\/em><\/p>\n<p>Thomas Pap <em>(M\u00fcnster, Germany)<\/em><\/p>\n<p>David Pisetsky <em>(Durham, USA)<\/em><\/p>\n<p>Zolt\u00e1n Szekanecz <em>(Debrecen, Hungary)<\/em><\/p>\n<p>Hiroshi Takayanagi <em>(Tokyo, Japan)<\/em><\/p>\n<p>Barbara Walzog <em>(Munich, Germany)<\/em><\/p>\n<p>Paul Winyard <em>(Exeter, UK)<\/em><\/p>\n<p><strong>Edit Buz\u00e1s, <\/strong><b><strong>Andr\u00e1s Falus, <\/strong><\/b><strong>Attila M\u00f3csai, <\/strong><b><strong>Gy\u00f6rgy Nagy<\/strong><\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Szeretettel h\u00edvjuk az \u00e9rdekl\u0151d\u0151ket az idei Semmelweis Symposiumra is, r\u00e9szletek az al\u00e1bbiakban olvashat\u00f3k. Szeretettel h\u00edvjuk az \u00e9rdekl\u0151d\u0151ket a 2013. nov. 7-9. k\u00f6z\u00f6tt az SE EOK \u00e9p\u00fclet\u00e9ben megrendez\u00e9sre ker\u00fcl\u0151 Semmelweis Symposium-ra, melynek t\u00e9m\u00e1ja &#8222;Molecular Mechanisms and Therapeutic Targets in Inflammatory Diseases&#8221; lesz. A f\u0151 el\u0151ad\u00e1st Ravinder Maini, a Lasker Award d\u00edjazottja, a TNF-antagonista ter\u00e1pia megalapoz\u00f3ja tartja. &hellip;<\/p>\n","protected":false},"author":158,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-152","post","type-post","status-publish","format-standard","hentry","category-hirek"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/posts\/152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/users\/158"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/comments?post=152"}],"version-history":[{"count":0,"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/posts\/152\/revisions"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/media?parent=152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/categories?post=152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/kerpel\/wp-json\/wp\/v2\/tags?post=152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}